Lamotrigine and Irritability

Evidence from Clinical Trials

In pediatric populations with autism spectrum disorder (ages 3-11 years), lamotrigine was associated with insomnia and hyperactivity as side effects, but not anxiety or irritability, according to the American Academy of Child and Adolescent Psychiatry guidelines 1
The American Academy of Child and Adolescent Psychiatry recommends considering alternative explanations for irritability in patients on lamotrigine, such as medication withdrawal syndrome or underlying mood disorder progression, with lamotrigine demonstrating limited efficacy in preventing manic episodes compared to depressive episodes 2

The American Academy of Child and Adolescent Psychiatry emphasizes that irritability in patients recovering from mood episodes may reflect challenges with returning to baseline functioning rather than medication effects, with a strength of evidence supporting the role of psychosocial stressors 3, 4

For patients with bipolar disorder, lamotrigine is effective maintenance therapy that significantly delays time to intervention for depressive episodes, but has limited efficacy for manic/hypomanic episodes, according to the American Psychiatric Association guidelines 2
If irritability emerges during lamotrigine treatment in a bipolar patient, this more likely represents an emerging manic/hypomanic episode requiring additional intervention rather than a lamotrigine side effect, with a moderate strength of evidence supporting this recommendation 2